# Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)

> **NCT02644421** · PHASE1 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 18 (actual)

## Conditions studied

- Radiculopathy
- Sciatica

## Interventions

- **DRUG:** VVZ-149
- **DRUG:** Lidocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02644421
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02644421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02644421, "Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02644421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*